Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

AXS-12 for the Treatment of Narcolepsy: Topline Results from the Phase 3 SYMPHONY Trial

Author:Thorpy, Michael   Krahn, Lois   Bogan, Richard   Corser, Bruce   Shapiro, Colin   Chhabra, Angad   Leary, Eileen   Tabuteau, Herriot   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Sleep  

Program Number:PL5.007  

Author Institution:Montefiore Medical Center, Bronx, NY  SleepMed, Columbia, SC  Intrepid Research, Cincinatti, OH  University of Toronto, Toronto, ON, Canada  Axsome Therapeutics, Inc., New York, NY  Axsome Therapeutics, Inc., San Francisco, CA  

Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Efficacy and Safety Results from the Phase 3 GEMINI 1 and 2 Trials

Author:Oh, Jiwon   Arnold, Douglas L.   Cree, Bruce A.C.   Ionete, Carolina   Kim, Ho Jin   Sormani, Maria Pia   Syed, Sana   Chen, Yixin   Maxwell, Christina R.   Benoit, Patrick   Turner, Timothy J.   Wallstroem, Erik   Wiendl, Heinz   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Multiple Sclerosis  

Program Number:PL5.008  

Author Institution:St. Michael’s Hospital, University of Toronto, Toronto, Canada, Toronto, ON, Canada  NeuroRx Research, Montréal, Canada, Montreal, QC, Canada  UCSF Weill Institute for Neurosciences, University of California San Francisco, Department of Neurology, San Francisco, United States, San Francisco, CA  UMass Chan Medical School, Worcester, United States, WORCESTER, MA  National Cancer Center, Department of Neurology, Goyang, South Korea, Goyang, Korea, Republic of  University of Genoa, Department of Health Sciences, Genoa, Italy, Genoa, Italy  Sanofi, Cambridge, United States, Cambridge, MA  Sanofi, Cambridge, United States, Mullica Hill, NJ  Sanofi, Chilly-Mazarin, France, Chilly Mazarin, France  Department of Neurology and Neurophysiology, University of Freiburg, Freiburg, Germany, Muenster, Germany  

Neuropalliative Care Symptoms and Distress in Patients with Multiple System Atrophy

Author:Cunningham, Rikki   Badihian, Negin   Chou, Claudia   Jackson, Lauren   Rhee, Laura   Coon, Elizabeth   

Session Name:P1: Autonomic Disorders 1  

Topic:Autonomic Disorders  

Program Number:P1.001  

Author Institution:Mayo Clinic, Rochester, MN  Cleveland Clinic, Cleveland, OH  

Outcomes for Patients with Generalized Myasthenia Gravis Prescribed Ravulizumab or Efgartigimod Treatment: A Retrospective Medical Record Analysis

Author:Scheiner, Christopher   Macwan, Samir   Streicher, Nicholas   Yee, Karen   Sader, Chloe   Blackowicz, Michael   Numapau, Nana   Gentile, Danielle   Sharpe, Jason   Pathak, Prathamesh   Pulley, Michael   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Myasthenia Gravis 1  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.001  

Author Institution:University of Tennessee Medical Center, Knoxville, TN  Eisenhower Health Center, Rancho Mirage, CA  MedStar Georgetown University Hospital, UT Neurology, Washington, DC  Alexion, AstraZeneca Rare Disease, Boston, MA  Cardinal Health, Dublin, OH  University of Florida College of Medicine, Jacksonville, FL  

Experiences of Women of Childbearing Age with Epilepsy Throughout their Motherhood Journey: Results From a Social Media Listening Study

Author:Manzo, Michelle   Baker, Gus   Koncz, Agnes   Shell, Michelle   Werhahn, Konrad   Wilkinson, Andrea   Smith, Jessica K.   Bourikas, Dimitrios   

Session Name:P1: Epilepsy/Clinical Neurophysiology (EEG): Special Populations: Women with Epilepsy, Caregivers, Adolescents, and Elderly  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P1.001  

Author Institution:UCB, Smyrna, GA  International Bureau for Epilepsy, Washington, DC  UCB, Brussels, Belgium  UCB, Monheim am Rhein, Germany  UCB, Emeryville, CA  Living Well With Epilepsy, Haddonfield, NJ  UCB, Alimos, Greece